Foster City, CA, United States of America

Qing Xu

This inventor holds 54 USPTO granted patents and 14 published patent applications, plus 3 CIPO patents and 18 EPO patents, primarily in Ferroportin Inhibitors. Top assignees: Global Blood Therapeutics, Inc., Portola Pharmaceuticals, Inc., Uber Technologies, Inc.. Active years: 2010-2026.

USPTO Granted Patents = 54 (Patent Applications = 14)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 18 (Patent Applications = 24)

Average Co-Inventor Count = 4.7

ph-index = 14

Forward Citations = 549(Granted Patents)

Forward Citations (Not Self Cited) = 453(Dec 10, 2025)

Location History:

South San Francisco, CA (US) (2015 - 2022)
Foster City, CA (US) (2010 - 2023)
Milpitas, CA (US) (2020 - 2023)
Santa Clara, CA (US) (2019 - 2024)

Company Filing History:

25 out of 59

Global Blood Therapeutics, Inc.

patents

22 out of 71

Portola Pharmaceuticals, Inc.

patents

6 out of 982

Uber Technologies, Inc.

patents

4. 1 out of 199

Alexion Pharmaceuticals, Inc.

patents

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Ferroportin Inhibitors

Hemoglobin Modulation

Histone Methyltransferase Inhibitors

Protein Kinase Inhibitors

Travel Coordination

Pickup Location Optimization

Bicyclic Kinase Inhibitors

Tricyclic Compounds

Syk Modulators

JAK Inhibitors

Pyrimidines

Dynamically Determining Locations

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12559502 - Thieno pyrimidines as ferroportin inhibitors (2026-02-24),

2. 12305996 - Dynamically determining origin and destination locations for a network system (2025-05-20),

3. 12202817 - Cycloalkyl pyrimidines as ferroportin inhibitors (2025-01-21),

4. 12025449 - Dynamically determining origin and destination locations for a network system (2024-07-02),

5. 11746100 - Cycloalkyl pyrimidines as ferroportin inhibitors (2023-09-05),

6. 11661410 - Tricyclic compounds as histone methyltransferase inhibitors (2023-05-30),

7. 11584734 - Tricyclic compounds as histone methyltransferase inhibitors (2023-02-21),

8. 11551325 - Travel coordination system implementing pick-up location optimization (2023-01-10),

9. 11530191 - Compounds and uses thereof for the modulation of hemoglobin (2022-12-20),

10. 11414410 - Inhibitors of protein kinases (2022-08-16),

11. 11286243 - Ferroportin inhibitors and methods of use (2022-03-29),

12. 11236109 - Compounds and uses thereof for the modulation of hemoglobin (2022-02-01),

13. 11150098 - Dynamically determining origin and destination locations for a network system (2021-10-19),

14. 11053195 - Compounds and uses thereof for the modulation of hemoglobin (2021-07-06),

15. 11014884 - Modulators of hemoglobin (2021-05-25),

Title: The Innovative Journey of Inventor Qing Xu

Introduction: Qing Xu, a pioneering inventor based in Foster City, CA, has made significant contributions to the field of technology with her groundbreaking inventions and patents.

Latest Patents: Qing Xu's latest patents include a cutting-edge artificial intelligence algorithm for predictive analytics and a revolutionary wearable device for monitoring vital signs in real-time.

Career Highlights: With a background in computer science and engineering, Qing Xu has a successful track record of developing innovative solutions for complex technological challenges. She has received multiple awards for her contributions to the industry.

Collaborations: Qing Xu has collaborated with leading tech companies and research institutions to further advance her inventions. Her partnerships have led to the successful implementation of her technologies in various sectors.

Conclusion: Qing Xu's dedication to innovation and her relentless pursuit of technological advancement continue to inspire the next generation of inventors. Her impact on the tech industry is profound, and her legacy as a visionary inventor is sure to endure for years to come.